Sophia Genetics SA
SOPH4.850USD
+0.050+1.04%
收盘 02/09, 16:00（美东）报价延迟15分钟
307.19M总市值
亏损市盈率 TTM
关于 Sophia Genetics SA 公司
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Sophia Genetics SA简介
公司代码SOPH
公司名称Sophia Genetics SA
上市日期Jul 23, 2021
CEOCamblong (Jurgi)
员工数量423
证券类型Ordinary Share
年结日Jul 23
公司地址La Piece 12
城市ROLLE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Switzerland
邮编CH-1180
电话41216941060
网址https://www.sophiagenetics.com/
公司代码SOPH
上市日期Jul 23, 2021
CEOCamblong (Jurgi)
Sophia Genetics SA公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+194164.00%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+48309.00%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-17644.00%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+48309.00%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+59409.00%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+66596.00%
Dr. Philippe Menu, M.D., Ph.D.
Dr. Philippe Menu, M.D., Ph.D.
Chief Medical Officer and Chief Product Officer
Chief Medical Officer and Chief Product Officer
39.60K
-2144.00%
Mr. Daan Van Well
Mr. Daan Van Well
Chief Legal and Compliance Officer
Chief Legal and Compliance Officer
--
--
Ms. Manuela Da Silva Valente
Ms. Manuela Da Silva Valente
Chief People Officer
Chief People Officer
--
--
Dr. Tomer Berkovitz, Ph.D.
Dr. Tomer Berkovitz, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+194164.00%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+48309.00%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-17644.00%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+48309.00%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+59409.00%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+66596.00%
收入明细
单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
由于公司未披露，未能获取相关数据
地区USD
名称
营收
占比
Rest of EMEA
6.63M
34.09%
France
3.12M
16.01%
United States
2.62M
13.45%
Italy
2.51M
12.89%
Spain
1.46M
7.48%
其他
3.13M
16.08%
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 2月1日 周日
更新时间: 2月1日 周日
持股股东
股东类型
持股股东
持股股东
占比
Alychlo NV
10.31%
Generation Investment Management LLP
10.01%
aMoon Fund
8.12%
Akre Capital Management, LLC
5.48%
Balderton Capital (UK) LLP
4.96%
其他
61.13%
持股股东
持股股东
占比
Alychlo NV
10.31%
Generation Investment Management LLP
10.01%
aMoon Fund
8.12%
Akre Capital Management, LLC
5.48%
Balderton Capital (UK) LLP
4.96%
其他
61.13%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
16.43%
Venture Capital
13.08%
Family Office
10.36%
Investment Advisor
8.51%
Individual Investor
6.43%
Hedge Fund
1.06%
Bank and Trust
0.46%
Research Firm
0.06%
Pension Fund
0.03%
其他
43.58%
机构持股
更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
82
26.92M
39.67%
-12.60M
2025Q3
76
26.89M
39.64%
-8.96M
2025Q2
89
36.69M
54.29%
-200.15K
2025Q1
93
36.63M
54.82%
-389.48K
2024Q4
93
32.50M
49.36%
-965.83K
2024Q3
91
34.60M
52.08%
+657.87K
2024Q2
92
32.44M
48.93%
+1.33M
2024Q1
93
31.91M
48.51%
+375.11K
2023Q4
91
30.61M
46.76%
-676.23K
2023Q3
91
30.34M
46.61%
-4.34M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Alychlo NV
6.99M
10.31%
--
--
Feb 15, 2025
Generation Investment Management LLP
6.79M
10.01%
--
--
Sep 30, 2025
aMoon Fund
5.51M
8.12%
+577.36K
+11.70%
Feb 15, 2025
Akre Capital Management, LLC
3.72M
5.48%
--
--
Sep 30, 2025
Balderton Capital (UK) LLP
3.36M
4.96%
--
--
Feb 15, 2025
Camblong (Jurgi)
2.65M
3.91%
+194.16K
+7.89%
Feb 15, 2025
Banque Pictet & Cie S.A.
2.21M
3.25%
--
--
Sep 30, 2025
Alta Wealth Advisors LLC
1.41M
2.08%
+1.41M
--
Sep 30, 2025
Principal Global Investors (Equity)
1.39M
2.05%
-8.95K
-0.64%
Sep 30, 2025
Ossipow (Vincent)
443.81K
0.65%
+48.31K
+12.21%
Feb 15, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Health Innovation Active ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
iShares Health Innovation Active ETF
占比0%
Fidelity Nasdaq Composite Index ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
